Results 41 to 50 of about 701,480 (245)

Some Practical Guidelines for Effective Sample-Size Determination in Observational Studies

open access: yesAceh International Journal of Science and Technology, 2013
- The purpose of this present study was to determine the right sample size in observational study which is focusing on medical or health sciences field. Sample size calculation is actually depends on the type of how the study is designed.
Wan Muhamad Amir Wan Ahmad   +3 more
doaj   +1 more source

Determination of the Sample Size on Different Independent K Group Comparisons by Power Analysis

open access: yesTürkiye Tarımsal Araştırmalar Dergisi, 2021
The purpose of this study was to determine the number of samples that should be used in independent treatment comparisons with different effect sizes (0.25-3.0), the number of treatments (2-5), and the power of the test (70% -95%) in single and multi ...
Emre ASLAN, Özgür KOŞKAN, Yasin ALTAY
doaj   +1 more source

Parent Quality of Life at Two Years Following Their Child's Completion of Acute Lymphoblastic Leukemia Treatment

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Parents of children treated for acute lymphoblastic leukemia (ALL) often experience significant caregiver burden and disruption to their well‐being. While parent quality of life (QoL) during treatment is well characterized, little is known about outcomes during early survivorship.
Sara Dal Pra   +3 more
wiley   +1 more source

Sample Size Determination in Randomised Controlled Clinical Trials: A Narrative Review [PDF]

open access: yesJournal of Clinical and Diagnostic Research
This article summarises efforts towards understanding the calculation of sample size determination in Randomised controlled Clinical Trials (RCTs). Readers would gain insight into the procedures behind sample size calculation in RCTs and its significance.
Rakesh Diliprao Kothavale   +3 more
doaj   +1 more source

Cognitive Functioning in Vorinostat‐Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Cognitive and psychological difficulties could negatively interfere with treatment adherence and quality of life before and after hematopoietic stem cell transplant (HSCT). Methods to mitigate these changes may have positive effects on treatment success.
Kristen L. Votruba   +11 more
wiley   +1 more source

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT A second allogeneic (allo‐)hematopoietic stem cell transplantation (HSCT2) is a potential curative option for pediatric patients with acute lymphoblastic leukemia (ALL) following relapse after first allogeneic transplantation (HSCT1), but its efficacy is limited by high relapse rates and transplant‐related toxicity in highly pretreated ...
Ava Momm   +10 more
wiley   +1 more source

Equivalence Test and Sample Size Determination Based on Odds Ratio in an AB/BA Crossover Study with Binary Outcomes

open access: yesAxioms
Crossover trials are specifically designed to evaluate treatment effects within individual participants through within-subject comparisons. In a standard AB/BA crossover trial, participants are randomly allocated to one of two treatment sequences: either
Shi-Fang Qiu, Xue-Qin Yu, Wai-Yin Poon
doaj   +1 more source

Experimental determination of size distributions: analyzing proper sample sizes [PDF]

open access: yesMeasurement Science and Technology, 2016
The measurement of various particle size distributions is a crucial aspect for many applications in the process industry. Size distribution is often related to the final product quality, as in crystallization or polymerization. In other cases it is related to the correct evaluation of heat and mass transfer, as well as reaction rates, depending on the ...
Alopaeus Ville, Buffo Antonio
openaire   +2 more sources

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender   +17 more
wiley   +1 more source

Determination of minimum training sample size for microarray-based cancer outcome prediction-an empirical assessment. [PDF]

open access: yesPLoS ONE, 2013
The promise of microarray technology in providing prediction classifiers for cancer outcome estimation has been confirmed by a number of demonstrable successes.
Li Shao   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy